Figure 1
From: Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
Sketch of the study design and pipeline. Candidate biomarkers were selected from meta-analysis to multiple high-throughput DNA methylation microarrays. The significant or best feature combination was screened in an independent validation study of non-small cell lung cancer (NSCLC) with the methylation status determined single nucleotide primer extension technique (MSD-SNuPET) technique.